Strides Pharma Science to get USD 20 mn funding for consumer healthcare business

Drug firm Strides Pharma Science Wednesday said it has partnered with funds advised by ICP-III Investment Advisors, which will infuse USD 20 million into its consumer healthcare business.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2zjASfe
via IFTTT